Mark Hurtt, MD

CMO

Dr. Hurtt has 25 years of industry experience in Clinical Development. After graduating from Jefferson Medical College and completing an internship at Thomas Jefferson University Hospital, he served as a medical officer in the United States Navy.

After a residency in neurology and neuropathology, he joined the faculty at the University of Pittsburgh. Dr. Hurtt’s career in clinical development began at Parke-Davis Pharmaceutical Research (acquired by Pfizer). Subsequently, Dr. Hurtt worked at Neurogen Corporation after which he went onto Alseres Pharmaceuticals, where he was Chief Medical Officer. Since 2010, he’s been a consultant to biotechnology and pharmaceutical companies, often serving as an interim Chief Medical Officer.